Your browser doesn't support javascript.
loading
Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology.
Yuan, Jie; Zhao, Di; Liu, Xue-Fang; Tian, Yan-Ge; Zhang, Hao-Jie; Feng, Su-Xiang; Li, Jian-Sheng.
Afiliação
  • Yuan J; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Zhao D; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
  • Liu XF; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
  • Tian YG; Academy of Chinese Medicine Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Zhang HJ; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
  • Feng SX; Academy of Chinese Medicine Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Li JS; Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
Sci Rep ; 12(1): 12476, 2022 07 21.
Article em En | MEDLINE | ID: mdl-35864295

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Fibrose Pulmonar / Medicamentos de Ervas Chinesas Tipo de estudo: Prognostic_studies Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Fibrose Pulmonar / Medicamentos de Ervas Chinesas Tipo de estudo: Prognostic_studies Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China